← Back to Search

Standard-risk patients who underwent carotid intervention for Carotid Artery Disease

N/A

Waitlist Available

Research Sponsored by Silk Road Medical

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2-years, 3-years, 4-years, and 5-years following the index procedure

Awards & highlights

No Placebo-Only Group

Summary

The study objective is to evaluate long-term outcomes for participants enrolled in the ROADSTER 3 study and treated with the ENROUTE Transcarotid Stent System (TSS) and ENROUTE Transcarotid Neuroprotection System (NPS).

Eligible Conditions

Carotid Artery Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2-years, 3-years, 4-years, and 5-years following the index procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2-years, 3-years, 4-years, and 5-years following the index procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-years, 3-years, 4-years, and 5-years following the index procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

In-stent Restenosis

Ipsilateral Stroke

Ipsilateral Stroke Mortality

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Standard-risk patients who underwent carotid interventionExperimental Treatment1 Intervention

Symptomatic or asymptomatic patients with a discrete lesion located in the internal carotid artery (ICA) with or without involvement of the contiguous common carotid artery (CCA), who underwent carotid artery revascularization.

Do I qualify?Apply below to find out